Angiogenesis
During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
- B5941 ONO-4059Summary: Highly potent and selective oral Btk inhibitor
- B6003 SB273005Summary: αvβ3 antagonist
- B6106 Daprodustat(GSK1278863)Summary: HIF-prolyl hydroxylase inhibitor
- B6185 ACP-196Target: BTKSummary: irreversible BTK inhibitor
- C4321 Octyl-α-ketoglutarateSummary: prolyl hydroxylases (PHD) activator
- C4377 AdaptaquinSummary: HIF-prolyl hydroxylase-2 (PHD2) inhibitor
- C4752 JNJ-42041935Summary: Hypoxia-inducible factor (HIF) prolyl hydroxylase (PHD) inhibitor
- C4887 2,4-DPDSummary: cell permeable, competitive inhibitor of HIF-PH
- B2298 Plinabulin (NPI-2358)Target: Vascular Disrupting Agents (VDA)Summary: vascular disrupting agent
- B1115 BAY 87-2243Target: Hypoxia Inducible Factors (HIFs)Summary: HIF-1 inhibitor,potent and selective